You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

INCB001158

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors, Metastatic Solid Tumors Trial in Chuo Ku, Kashiwa (Retifanlimab, INCB001158, Retifanlimab + INCB001158)

Completed
  • Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Chuo Ku, Japan
  • +1 more
Feb 24, 2022

Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States

Completed
  • Biliary Tract Cancer (BTC)
  • +5 more
  • INCB001158
  • +6 more
  • Birmingham, Alabama
  • +9 more
Dec 22, 2022

Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

Active, not recruiting
Has Results
  • Metastatic Cancer
  • +9 more
  • Mobile, Alabama
  • +19 more
Aug 1, 2022

Relapsed or Refractory Multiple Myeloma Trial in Germany, Spain, United States (INCB001158, Daratumumab SC)

Completed
  • Relapsed or Refractory Multiple Myeloma
  • INCB001158
  • Daratumumab SC
  • Daphne, Alabama
  • +28 more
May 5, 2022

Solid Tumors Trial in Birmingham, Chicago (INCB001158, Epacadostat, Pembrolizumab)

Terminated
Has Results
  • Solid Tumors
  • INCB001158
  • +2 more
  • Birmingham, Alabama
  • +1 more
May 11, 2020